Original Article

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals
  • Sibel YILDIZ KAYA
  • Bilgül METE
  • Abdurrahman KAYA
  • Ilker Inanç BALKAN
  • Nese SALTOGLU
  • Fehmi TABAK
Viral Hepat J 2017; 23: 6-9 DOI: 10.4274/vhd.52724
Full
Text

Research Article

Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus
  • Özlem Kuman Tunçel
  • Deniz Akyol
  • Hüsnü Pullukçu
  • Tansu Yamazhan
  • Meltem Işıkgöz Taşbakan
  • Özen Önen Sertöz
Viral Hepat J 2019; 25: 25-31 DOI: 10.4274/vhd.galenos.2019.0006
Full
Text
Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
  • Mustafa Doğan
  • Birol Topçu
  • Rıtvan Karaali
  • İlknur Erdem
Viral Hepat J 2020; 26: 43-48 DOI: 10.4274/vhd.galenos.2020.2020.0016
Full
Text
Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
  • Tuba Damar Çakırca
  • Tansu Yamazhan
  • Esra Yüksekkaya
  • Fethiye Akgül
  • Behice Kurtaran
  • Ömer Karaşahin
  • Oğuz Karabay
  • Gülten Ünlü
  • İlkay Nur Can
  • Hüsnü Pullukçu
  • Yeşim Taşova
  • Süheyla Kömür
  • Yeşim Yıldız
  • Çiğdem Mermutluoğlu
  • Yakup Demir
  • Mustafa Kemal Çelen
Viral Hepat J 2023; 29: 58-63 DOI: 10.4274/vhd.galenos.2023.2023-5-2
Full
Text
Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
  • Mehmet Çabalak
  • Tayibe Bal
Viral Hepat J 2020; 26: 61-64 DOI: 10.4274/vhd.galenos.2020.2020.0015
Full
Text
Advanced Search

About Journal

Forms

Useful Links

Subscribe
Latest Update: 26.12.2023
2024 © Galenos Publishing House.